Dear Colleagues,

We are pleased to announce that the winner of the Pharmaceuticals 2022 Young Investigator Award is Dr. Daniele Bertoglio.

Dr. Daniele Bertoglio is a Tenure-Track Assistant Professor of the Department of Biomedical Sciences at the University of Antwerp, Antwerp, Belgium. His overarching research focus is to accelerate the development of therapies to cure neurological disorders by pushing the boundaries of translational neuroimaging techniques in preclinical models of neurological diseases, with a focus on Huntington’s disease, spinal cord injury, Alzheimer’s disease, and epilepsy. Dr. Daniele Bertoglio holds two PhDs in preclinical neuroimaging of brain disorders and has an outstanding publication record, comprising 30 publications in peer-reviewed international journals of which 17 publications are as the lead author. Dr. Bertoglio has already received several national and international awards acknowledging his groundbreaking contributions to preclinical neuroimaging. He is clearly a rising star in the field of experimental neuroimaging. Dr. Bertoglio has contributed to securing funding of more than EUR 8 million since 2017. This is an outstanding achievement in today’s competitive environment. Please join us in congratulating Dr. Daniele Bertoglio on his outstanding achievements.

As the awardee, Dr. Daniele Bertoglio will receive an honorarium of CHF 2000, an offer to publish a paper free of charge before 31 December 2023 in Pharmaceuticals after peer-review, and an electronic certificate.

We would like to thank all the nominators from various fields of study for their participation and all the Award Committee Members for their evaluation of the many excellent nominations.

Pharmaceuticals 2022 Young Investigator Evaluation Committee